Randomised controlled trial comparing the spinal sensory level achieved, duration of action and safety of generic (Bupivacaine 0.5% with Dextrose-PharmaQ) versus original bupivacaine (Macaine 0.5% with dextrose-Adcock Ingram) in spinal anaesthesia
Not Applicable
- Conditions
- Anaesthesia
- Registration Number
- PACTR201807735986564
- Lead Sponsor
- Pireshin Ramdharee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 72
Inclusion Criteria
Male patients
18 - 50 years old
Healthy patients - American Society of Anaesthesiologists physical status grade one and two
Exclusion Criteria
Contraindication to spinal anaesthesia
Local anaesthetic allergy
Patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparing the sensory level achieved by generic to the original drug
- Secondary Outcome Measures
Name Time Method Comparing the decrease in the sensory level after 30, 60 and 90 minutes;Comparing the side effects observed betwen generic and original drug